131 related articles for article (PubMed ID: 25900642)
1. Permeation enhancement via thiolation: in vitro and ex vivo evaluation of hyaluronic acid-cysteine ethyl ester.
Laffleur F; Psenner J; Suchaoin W
J Pharm Sci; 2015 Jul; 104(7):2153-60. PubMed ID: 25900642
[TBL] [Abstract][Full Text] [Related]
2. Thiolated nanocarriers for oral delivery of hydrophilic macromolecular drugs.
Dünnhaupt S; Barthelmes J; Köllner S; Sakloetsakun D; Shahnaz G; Düregger A; Bernkop-Schnürch A
Carbohydr Polym; 2015 Mar; 117():577-584. PubMed ID: 25498673
[TBL] [Abstract][Full Text] [Related]
3. In vitro and ex vivo evaluation of biomaterials' distinctive properties as a result of thiolation.
Laffleur F; Wagner J; Mahmood A
Future Med Chem; 2015; 7(4):449-57. PubMed ID: 25875872
[TBL] [Abstract][Full Text] [Related]
4. Thiolated polycarbophil/glutathione: defining its potential as a permeation enhancer for oral drug administration in comparison to sodium caprate.
Perera G; Barthelmes J; Vetter A; Krieg C; Uhlschmied C; Bonn GK; Bernkop-Schnürch A
Drug Deliv; 2011 Aug; 18(6):415-23. PubMed ID: 21554106
[TBL] [Abstract][Full Text] [Related]
5. A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa.
Makhlof A; Werle M; Tozuka Y; Takeuchi H
J Control Release; 2011 Jan; 149(1):81-8. PubMed ID: 20138935
[TBL] [Abstract][Full Text] [Related]
6. Oral absorption enhancement of salmon calcitonin by using both N-trimethyl chitosan chloride and oligoarginines-modified liposomes as the carriers.
Huang A; Su Z; Li S; Sun M; Xiao Y; Ping Q; Deng Y
Drug Deliv; 2014 Aug; 21(5):388-96. PubMed ID: 24188463
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vitro evaluation of thiolated hyaluronic acid for mucoadhesive drug delivery.
Kafedjiiski K; Jetti RK; Föger F; Hoyer H; Werle M; Hoffer M; Bernkop-Schnürch A
Int J Pharm; 2007 Oct; 343(1-2):48-58. PubMed ID: 17544606
[TBL] [Abstract][Full Text] [Related]
8. Bioactive self-assembling lipid-like peptides as permeation enhancers for oral drug delivery.
Karavasili C; Spanakis M; Papagiannopoulou D; Vizirianakis IS; Fatouros DG; Koutsopoulos S
J Pharm Sci; 2015 Jul; 104(7):2304-11. PubMed ID: 25994901
[TBL] [Abstract][Full Text] [Related]
9. Impact of amino acid replacements on in vitro permeation enhancement and cytotoxicity of the intestinal absorption promoter, melittin.
Maher S; Devocelle M; Ryan S; McClean S; Brayden DJ
Int J Pharm; 2010 Mar; 387(1-2):154-60. PubMed ID: 20025949
[TBL] [Abstract][Full Text] [Related]
10. HEC-cysteamine particles: influence of particle size, zeta potential, morphology and sulfhydryl groups on permeation enhancing properties.
Rahmat D; Müller C; Shahnaz G; Leithner K; Laffleur F; Khan MI; Martien R; Bernkop Schnürch A
Drug Dev Ind Pharm; 2013 Sep; 39(9):1338-45. PubMed ID: 22901004
[TBL] [Abstract][Full Text] [Related]
11. Preactivated thiomers: permeation enhancing properties.
Wang X; Iqbal J; Rahmat D; Bernkop-Schnürch A
Int J Pharm; 2012 Nov; 438(1-2):217-24. PubMed ID: 22960503
[TBL] [Abstract][Full Text] [Related]
12. Improvement of intestinal absorption of insulin and water-soluble macromolecular compounds by chitosan oligomers in rats.
Gao Y; He L; Katsumi H; Sakane T; Fujita T; Yamamoto A
Int J Pharm; 2008 Jul; 359(1-2):70-8. PubMed ID: 18450395
[TBL] [Abstract][Full Text] [Related]
13. Efficacious intestinal permeation enhancement induced by the sodium salt of 10-undecylenic acid, a medium chain fatty acid derivative.
Brayden DJ; Walsh E
AAPS J; 2014 Sep; 16(5):1064-76. PubMed ID: 24961919
[TBL] [Abstract][Full Text] [Related]
14. Thiolated hydroxyethyl cellulose: design and in vitro evaluation of mucoadhesive and permeation enhancing nanoparticles.
Rahmat D; Müller C; Barthelmes J; Shahnaz G; Martien R; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2013 Feb; 83(2):149-55. PubMed ID: 23148989
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticles based on N-trimethylchitosan: evaluation of absorption properties using in vitro (Caco-2 cells) and ex vivo (excised rat jejunum) models.
Sandri G; Bonferoni MC; Rossi S; Ferrari F; Gibin S; Zambito Y; Di Colo G; Caramella C
Eur J Pharm Biopharm; 2007 Jan; 65(1):68-77. PubMed ID: 16962751
[TBL] [Abstract][Full Text] [Related]
16. [Stabilized thiomer PAA-Cys-6MNA].
Yang JS; Chen XH; Zhang H; Dai WB; Wang XQ; Zhang Q
Yao Xue Xue Bao; 2014 Jun; 49(6):942-8. PubMed ID: 25212045
[TBL] [Abstract][Full Text] [Related]
17. Rhamnolipids as epithelial permeability enhancers for macromolecular therapeutics.
Perinelli DR; Vllasaliu D; Bonacucina G; Come B; Pucciarelli S; Ricciutelli M; Cespi M; Itri R; Spinozzi F; Palmieri GF; Casettari L
Eur J Pharm Biopharm; 2017 Oct; 119():419-425. PubMed ID: 28743594
[TBL] [Abstract][Full Text] [Related]
18. A potential tailor-made hyaluronic acid buccal delivery system comprising rotigotine for Parkinson's disease?
Laffleur F; Wagner J; Barthelmes J
Future Med Chem; 2015; 7(10):1225-32. PubMed ID: 26144261
[TBL] [Abstract][Full Text] [Related]
19. HEC-cysteamine conjugates: influence of degree of thiolation on efflux pump inhibitory and permeation enhancing properties.
Rahmat D; Sakloetsakun D; Shahnaz G; Sarti F; Laffleur F; Schnürch AB
Int J Pharm; 2012 Jan; 422(1-2):40-6. PubMed ID: 22027393
[TBL] [Abstract][Full Text] [Related]
20. The role of glutathione in the permeation enhancing effect of thiolated polymers.
Clausen AE; Kast CE; Bernkop-Schnürch A
Pharm Res; 2002 May; 19(5):602-8. PubMed ID: 12069161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]